Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempest Therapeutics Inc.

7.10
+0.25003.65%
Volume:44.64K
Turnover:305.82K
Market Cap:24.84M
PE:-0.36
High:7.10
Open:7.03
Low:6.65
Close:6.85
Loading ...
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2022

Major Issues Report

8-K - Current report
Jun 21, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 09, 2022

Major Issues Report

8-K - Current report
May 26, 2022

Major Issues Report

8-K - Current report
May 24, 2022

Correspondence

CORRESP [Cover] - Correspondence
May 13, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 13, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
May 02, 2022

Major Issues Report

8-K - Current report
Apr 01, 2022

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2022

Major Issues Report

8-K - Current report
Mar 29, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 17, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals